Literature DB >> 2575036

Inhibition of dopamine release by methylenedioxymethamphetamine is mediated by serotonin.

R A Gazzara1, H Takeda, A K Cho, S G Howard.   

Abstract

(+/-)-3,4-Methylenedioxymethamphetamine (MDMA), at doses of 0.1, 1 and 10 mg/kg, produced a long-lasting decrease in extracellular dopamine concentration in the neostriatum of anesthetized rats, as measured by in vivo voltammetry. Since MDMA has been shown to release serotonin from rat brain slices and synaptosomes, we examined the possibility that increased serotonin release might be the cause of the decrease in dopamine release. Rats were treated with d,l-p-chloroamphetamine seven days prior to acute MDMA administration. Rats pretreated with p-chloroamphetamine, which produced a marked decrease in serotonin content, showed no significant decrease in extracellular dopamine concentration when administered 10 mg/kg MDMA. These data suggest that MDMA produces a significant decrease in dopamine release when administered acutely, and that this decrease is an indirect effect mediated by an increase in serotonin release.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2575036     DOI: 10.1016/0014-2999(89)90567-0

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  4 in total

Review 1.  Effects of p-chloroamphetamine on brain serotonin neurons.

Authors:  R W Fuller
Journal:  Neurochem Res       Date:  1992-05       Impact factor: 3.996

2.  Amphetamine derivatives induce locomotor hyperactivity by acting as indirect serotonin agonists.

Authors:  C W Callaway; M P Johnson; L H Gold; D E Nichols; M A Geyer
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

Review 3.  Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy").

Authors:  A R Green; A J Cross; G M Goodwin
Journal:  Psychopharmacology (Berl)       Date:  1995-06       Impact factor: 4.530

4.  The Effects of Fasting During Ramadan on the Concentration of Serotonin, Dopamine, Brain-Derived Neurotrophic Factor and Nerve Growth Factor.

Authors:  Abdolhossein Bastani; Sadegh Rajabi; Fatemeh Kianimarkani
Journal:  Neurol Int       Date:  2017-06-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.